CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Oxytocin Antagonist in Patients With Repeated Failure of Implantation [Phase 4]
Summary
Phase 4 clinical trial update for an oxytocin antagonist in patients with repeated implantation failure has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AZ Jan Palfijn Gent | Conditions: Implantation Failure | Phase 4 | Status: COMPLETED